• Could GLP2 receptor agonists be a new frontier in weight management medication?

  • Sep 28 2024
  • Length: 4 mins
  • Podcast

Could GLP2 receptor agonists be a new frontier in weight management medication?

Listen for free

View show details

  • Summary

  • We are now very well acquainted with the efficacy of GLP1 receptor agonists (GLP1RAs) in weight management, like semaglutide (Wegovy/Ozempic) and liraglutide (Saxenda), and the dual GLP1/GIP agonist tirzepatide (Zepbound/Mounjaro). What is GLP2 (yes two), and could GLP2 receptor agonism be an untapped frontier in weight management medication?

    Learn more: https://drsue.ca/2024/09/could-glp2-receptor-agonists-be-a-new-frontier-in-weight-management-medication/

    Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. This podcast is not designed to give specific medical advice to patients, nor to their health care providers. If you have a medical problem you should consult your own physician for advice specific to your own situation. Postings on this podcast represent the personal opinions of Dr. Sue Pedersen. They are not representative of, nor endorsed by, Alberta Health Services. This podcast is intended for the Canadian general public as well as Canadian allied health professionals.
    Show more Show less
Show more Show less

What listeners say about Could GLP2 receptor agonists be a new frontier in weight management medication?

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available